cimetidine

Cimetidine (SKF-92334) is a histamine congener, it competitively inhibits HISTAMINE binding to HISTAMINE H2 RECEPTORS. Cimetidine has a range of pharmacological actions. It inhibits GASTRIC ACID secretion, as well as PEPSIN and GASTRIN output.

Cimetidine sulfoxide (Cimetidine sulphoxide), a metabolite of Cimetidine, is a histamine H2-receptor antagonist with potential applications in treating peptic ulcer disease and upper gastrointestinal hemorrhage [1].

Cimetidine (SKF-92334) hydrochloride is an orally active inverse histamine H2 receptor antagonist with a Ki of 0.6 μM, demonstrating anti-cancer and anti-inflammatory activity, and is a gastric acid reducer useful in the research of duodenal and gastric ulcers [1] [2] [5].

Cimetidine-D3 is the deuterated analog of Cimetidine. Cimetidine (T0797) (SKF-92334) is an orally active, reversible histamine H2 receptor antagonist with a Ki of 0.6 μM, and it also acts as an inverse agonist. Additionally, Cimetidine (T0797) exhibits anti-cancer and anti-inflammatory properties.

Cimetidine (Standard) is the standard substance of Cimetidine, and it is applicable for quantitative analysis, quality control, and related research in biochemical experiments. Cimetidine (SKF-92334) is a histamine congener, it competitively inhibits HISTAMINE binding to HISTAMINE H2 RECEPTORS. Cimetidine has a range of pharmacological actions. It inhibits GASTRIC ACID secretion, as well as PEPSIN and GASTRIN output.

Picartamide demonstrates potent antisecretory and anti-ulcer properties, with an efficacy that exceeds cimetidine by at least tenfold.

2-Cyano-1,3-dimethylguanidine is an impurity of Cimetidine.